Gene · 780
Papers2,465
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 2,465
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Inhibition of Adipose Tissue Beiging by HIV Integrase Inhibitors, Dolutegravir and Bictegravir, Is Associated with Adipocyte Hypertrophy, Hypoxia, Elevated Fibrosis, and Insulin Resistance in Simian Adipose Tissue and Human Adipocytes. | Cells | 2022 | 35681536 | PubTator, text mining | PubMed |
| Discoidin domain receptor 1 may be involved in biological barrier homeostasis. | J Clin Pharm Ther | 2022 | 35665520 | PubTator, text mining | PubMed |
| Identification of Synergistic Drug Combinations to Target KRAS-Driven Chemoradioresistant Cancers Utilizing Tumoroid Models of Colorectal Adenocarcinoma and Recurrent Glioblastoma. | Front Oncol | 2022 | 35664781 | PubTator, text mining | PubMed |
| CircRNA PVT1 modulated cell migration and invasion through Epithelial-Mesenchymal Transition (EMT) mediation in gastric cancer through miR-423-5p/Smad3 pathway. | Regen Ther | 2022 | 35663842 | PubTator, text mining | PubMed |
| Tumor specifically internalizing peptide 'HN-1': Targeting the putative receptor retinoblastoma-regulated discoidin domain receptor 1 involved in metastasis. | World J Clin Oncol | 2022 | 35662982 | PubTator, text mining | PubMed |
| Advantages of Rho-associated kinases and their inhibitor fasudil for the treatment of neurodegenerative diseases. | Neural Regen Res | 2022 | 35662192 | PubTator, text mining | PubMed |
| Update on the pathogenesis of vitiligo. | An Bras Dermatol | 2022 | 35643735 | PubTator, text mining | PubMed |
| Validation of Novel Molecular Imaging Targets Identified by Functional Genomic mRNA Profiling to Detect Dysplasia in Barrett's Esophagus. | Cancers (Basel) | 2022 | 35626066 | PubTator, text mining | PubMed |
| Current and Emerging Approaches to Study Microenvironmental Interactions and Drug Activity in Classical Hodgkin Lymphoma. | Cancers (Basel) | 2022 | 35626032 | PubTator, text mining | PubMed |
| Obesity, Diabetes, and Cancer: The Role of the Insulin/IGF Axis; Mechanisms and Clinical Implications. | Biomolecules | 2022 | 35625539 | PubTator, text mining | PubMed |
| Emerging roles of cystathionine β-synthase in various forms of cancer. | Redox Biol | 2022 | 35618601 | PubTator, text mining | PubMed |
| Glomerular basement membrane deposition of collagen α1(III) in Alport glomeruli by mesangial filopodia injures podocytes via aberrant signaling through DDR1 and integrin α2β1. | J Pathol | 2022 | 35607980 | PubTator, text mining | PubMed |
| Extracellular vesicle biomarkers for pancreatic cancer diagnosis: a systematic review and meta-analysis. | BMC Cancer | 2022 | 35606727 | PubTator, text mining | PubMed |
| Inability to phosphorylate Y88 of p27Kip1 enforces reduced p27 protein levels and accelerates leukemia progression. | Leukemia | 2022 | 35597806 | PubTator, text mining | PubMed |
| DDR1 promotes LoVo cell proliferation by regulating energy metabolism. | Acta Biochim Biophys Sin (Shanghai) | 2022 | 35593476 | PubTator, text mining | PubMed |
| Integration of bioinformatics analysis and experimental validation identifies plasma exosomal miR-103b/877-5p/29c-5p as diagnostic biomarkers for early lung adenocarcinoma. | Cancer Med | 2022 | 35585716 | PubTator, text mining | PubMed |
| Epigenetic Regulations of Perineural Invasion in Head and Neck Squamous Cell Carcinoma. | Front Genet | 2022 | 35571032 | PubTator, text mining | PubMed |
| Overcoming Therapy Resistance in Colon Cancer by Drug Repurposing. | Cancers (Basel) | 2022 | 35565237 | PubTator, text mining | PubMed |
| Discoidin domain receptor 1 promotes lung adenocarcinoma migration via the AKT/snail signaling axis. | Mol Biol Rep | 2022 | 35562515 | PubTator, text mining | PubMed |
| Bioluminescent Zebrafish Transplantation Model for Drug Discovery. | Front Pharmacol | 2022 | 35559262 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/780/papers?page=34